| For: | Tanaka H, Tsuruga K, Aizawa-Yashiro T, Watanabe S, Imaizumi T. Treatment of young patients with lupus nephritis using calcineurin inhibitors. World J Nephrol 2012; 1(6): 177-183 [PMID: 24175257 DOI: 10.5527/wjn.v1.i6.177] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v1/i6/177.htm |
| Number | Citing Articles |
| 1 |
H Tanaka, T Aizawa, S Watanabe, E Oki, K Tsuruga, T Imaizumi. Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis. Lupus 2014; 23(8) doi: 10.1177/0961203314528553
|
| 2 |
Hiroshi Tanaka, Kensuke Joh, Tadaatsu Imaizumi. Treatment of pediatric-onset lupus nephritis: a proposal of optimal therapy. Clinical and Experimental Nephrology 2017; 21(5) doi: 10.1007/s10157-017-1381-1
|
| 3 |
Yuichi Muraki, Shugo Mizuno, Kaname Nakatani, Hiroki Wakabayashi, Eiji� Ishikawa, Toshimitsu Araki, Akira Taniguchi, Shuji Isaji, Masahiro Okuda. Monitoring of peripheral blood cluster of differentiation 4+ adenosine triphosphate activity and CYP3A5 genotype to determine the pharmacokinetics, clinical effects and complications of tacrolimus in patients with autoimmune diseases. Experimental and Therapeutic Medicine 2017; doi: 10.3892/etm.2017.5364
|
| 4 |
Xiaoyan Zhang, Ling Ji, Lichuan Yang, Xiaohong Tang, Wei Qin. The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis. International Urology and Nephrology 2016; 48(5) doi: 10.1007/s11255-015-1201-z
|
| 5 |
Yanxinli Han, Hongyu Sha, Lanqi Zhou, Yuan Yang, Yi Wang, Zhuowei Yu, Liru Qiu, Yu Zhang, Jianhua Zhou. A study of calcineurin inhibitors in comparison with intravenous cyclophosphamide for initial induction treatment of lupus nephritis class Ⅲ, Ⅳ, V in Chinese children. Lupus 2025; 34(9) doi: 10.1177/09612033251351338
|
| 6 |
Chi Liu, Zhidan Wang, Xin Hu, Hidenori Ito, Kiwamu Takahashi, Motowo Nakajima, Tohru Tanaka, Ping Zhu, Xiao-Kang Li. 5-aminolevulinic acid combined with sodium ferrous citrate ameliorated lupus nephritis in a mouse chronic graft-versus-host disease model. International Immunopharmacology 2021; 96 doi: 10.1016/j.intimp.2021.107626
|
| 7 |
Kana N. Miyata, Hiromi Kihira, Manabu Haneda, Yasuhide Nishio. IgG4-Related Tubulointerstitial Nephritis Associated with Membranous Nephropathy in Two Patients: Remission after Administering a Combination of Steroid and Mizoribine. Case Reports in Nephrology 2014; 2014 doi: 10.1155/2014/678538
|
| 8 |
Yumeng Zhang, Jin Zhao, Yunlong Qin, Yuwei Wang, Zixian Yu, Xiaoxuan Ning, Shiren Sun. Specific alterations of gut microbiota in patients with membranous nephropathy: A systematic review and meta-analysis. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.909491
|
| 9 |
Hiroshi Tanaka, Tomomi Aizawa, Morito Endo. Long‐term outcome of tacrolimus‐based immunosuppressive treatment for patients with paediatric‐onset lupus nephritis. Nephrology 2024; 29(12) doi: 10.1111/nep.14406
|
| 10 |
Yukihiko Kawasaki, Shinichiro Ohara, Kyohei Miyazaki, Shuto Kanno, Atsushi Ono, Kazuhide Suyama, Masatoki Sato, Shigeo Suzuki, Ryo Maeda, Katsutoshi Nagasawa, Mitsuaki Hosoya. Incidence and prognosis of systemic lupus erythematosus in a 35 year period in Fukushima, Japan. Pediatrics International 2015; 57(4) doi: 10.1111/ped.12588
|
| 11 |
Dionysis Nikolopoulos, Lampros Fotis, Ourania Gioti, Antonis Fanouriakis. Tailored treatment strategies and future directions in systemic lupus erythematosus. Rheumatology International 2022; 42(8) doi: 10.1007/s00296-022-05133-0
|
| 12 |
Daniela S. Ardelean, Michelle Letarte. Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia. Frontiers in Genetics 2015; 6 doi: 10.3389/fgene.2015.00035
|
| 13 |
D. Roselyn Cerutis. Reference Module in Biomedical Sciences. 2014; doi: 10.1016/B978-0-12-801238-3.05336-8
|